<DOC>
	<DOCNO>NCT02766855</DOCNO>
	<brief_summary>The aim study evaluate efficacy topical cysteamine eye drop treatment corneal cystine crystal deposit patient nephropathic cystinosis .</brief_summary>
	<brief_title>Efficacy Topical Cysteamine Nephropathic Cyctinosis</brief_title>
	<detailed_description>A total 26 patient nephropathic cystinosis include prospective study . Patients evaluate improvement corneal cysteine deposit crystal photophobia follow treatment topical 0.55 % cysteamine eye drop .</detailed_description>
	<mesh_term>Cysteamine</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>patient confirm diagnosis nephropathic cystinosis leucocyte cystine concentration level 2.0 nmol halfcystine/ mg protein clinical evidence tissue deposition cystine tissue damage due cystinosis Allergy cysteamine</criteria>
	<gender>All</gender>
	<minimum_age>8 Months</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>cysteamine</keyword>
	<keyword>nephropathic cystinosis</keyword>
	<keyword>cystine crystal</keyword>
</DOC>